259 related articles for article (PubMed ID: 11877256)
1. Myeloid cell factor-1 is a critical survival factor for multiple myeloma.
Zhang B; Gojo I; Fenton RG
Blood; 2002 Mar; 99(6):1885-93. PubMed ID: 11877256
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma.
Gupta VA; Matulis SM; Conage-Pough JE; Nooka AK; Kaufman JL; Lonial S; Boise LH
Blood; 2017 Apr; 129(14):1969-1979. PubMed ID: 28151428
[TBL] [Abstract][Full Text] [Related]
3. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.
Derenne S; Monia B; Dean NM; Taylor JK; Rapp MJ; Harousseau JL; Bataille R; Amiot M
Blood; 2002 Jul; 100(1):194-9. PubMed ID: 12070027
[TBL] [Abstract][Full Text] [Related]
4. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1.
Gojo I; Zhang B; Fenton RG
Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644
[TBL] [Abstract][Full Text] [Related]
6. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M
Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232
[TBL] [Abstract][Full Text] [Related]
7. The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells.
Gomez-Bougie P; Bataille R; Amiot M
Eur J Immunol; 2004 Nov; 34(11):3156-64. PubMed ID: 15459900
[TBL] [Abstract][Full Text] [Related]
8. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T
Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin.
Andersson Y; Juell S; Fodstad Ø
Int J Cancer; 2004 Nov; 112(3):475-83. PubMed ID: 15382075
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.
Song L; Coppola D; Livingston S; Cress D; Haura EB
Cancer Biol Ther; 2005 Mar; 4(3):267-76. PubMed ID: 15753661
[TBL] [Abstract][Full Text] [Related]
11. The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism.
Pei XY; Dai Y; Grant S
Mol Cancer Ther; 2004 Dec; 3(12):1513-24. PubMed ID: 15634644
[TBL] [Abstract][Full Text] [Related]
12. VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis.
Le Gouill S; Podar K; Amiot M; Hideshima T; Chauhan D; Ishitsuka K; Kumar S; Raje N; Richardson PG; Harousseau JL; Anderson KC
Blood; 2004 Nov; 104(9):2886-92. PubMed ID: 15217829
[TBL] [Abstract][Full Text] [Related]
13. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells.
Weng C; Li Y; Xu D; Shi Y; Tang H
J Biol Chem; 2005 Mar; 280(11):10491-500. PubMed ID: 15637055
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide antibiotic actinomycin D induces Mcl-1 uncanonical downregulation in lung cancer cell apoptosis.
Chen CL; Tseng PC; Chao YP; Shen TJ; Jhan MK; Wang YT; Nguyen TT; Lin CF
Life Sci; 2023 May; 321():121615. PubMed ID: 37001403
[TBL] [Abstract][Full Text] [Related]
15. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1.
Derouet M; Thomas L; Moulding DA; Akgul C; Cross A; Moots RJ; Edwards SW
J Immunol; 2006 Jan; 176(2):957-65. PubMed ID: 16393981
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 inhibits all-trans retinoic acid-induced apoptosis.
Soucek K; Pacherník J; Kubala L; Vondrácek J; Hofmanová J; Kozubík A
Leuk Res; 2006 May; 30(5):607-23. PubMed ID: 16242776
[TBL] [Abstract][Full Text] [Related]
17. Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
Gomez-Bougie P; Oliver L; Le Gouill S; Bataille R; Amiot M
Oncogene; 2005 Dec; 24(54):8076-9. PubMed ID: 16091744
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and translational control of Mcl-1 during apoptosis.
Iglesias-Serret D; Piqué M; Gil J; Pons G; López JM
Arch Biochem Biophys; 2003 Sep; 417(2):141-52. PubMed ID: 12941295
[TBL] [Abstract][Full Text] [Related]
19. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
[TBL] [Abstract][Full Text] [Related]
20. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.
Pérez-Galán P; Roué G; Villamor N; Montserrat E; Campo E; Colomer D
Blood; 2006 Jan; 107(1):257-64. PubMed ID: 16166592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]